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Abstract
Metabolic syndrome is a serious health problem in the United States. The
presence of metabolic syndrome significantly increases the risk of developing type II
diabetes and cardiovascular disease by producing a prothrombic state. The prothrombic
state that results from the clustering of several independent cardiovascular risk factors
within one individual increases the risk of micro and macro vascular changes and
eventually to end organ damage.
There is considerable evidence to support the serious nature of this medical
condition. Medications used to treat the hypertension, diabetic, and dyslipidemia
components of metabolic syndrome can be a significant drain on the monthly budget of
individuals and families, especially if they do not have health insurance. Diet and
exercise programs have been shown to be effective in reducing adiposity and decreasing
insulin resistance. These changes in lifestyle may be adjuncts or a low cost alternative to
expensive medications for some individuals. The purpose of this project was to identify
the effect of an intensive dietary and exercise program on patients with metabolic
syndrome.
This study even with a small sample size (n = 5) showed that waist size, systolic
blood pressure, diastolic blood pressure, and high density lipoprotein levels were trending
towards levels that would remove the patient from the diagnosis of metabolic syndrome.
The greatest benefit for the general population would result from intervention prior to a
diagnosis of hypertension and diabetes and with medication naïve individuals. Early
intervention would decrease the cost of medical treatment and hospitalizations.

Chapter One: Introduction
Metabolic syndrome is the grouping of interrelated metabolic risk factors within a single
individual. The metabolic syndrome, first described in the 1920s, has been the subject of
extensive research since the mid to late 1990’s (Johnson & Weinstock, 2006). This clustering of
risk factors increases the risk of developing type II diabetes (DM II) and coronary heart disease
(CHD) (Stone & Schmeltz, 2007). Four expert groups have developed diagnostic definitions:
The National Cholesterol Educational Program’s Adult Treatment Panel III (ATP III), the
International Diabetes Federation (IDF), the American Heart Association/National Heart, Lung,
and Blood Institute (NCEP-R), and the World Health Federation (WHO).
The ATP III, NCEP-R, and IDF use waist circumference, triglyceride level, HDL
cholesterol level, blood pressure, and fasting glucose as diagnostic criteria. The WHO criteria
include these same five elements as well as, microalbuminuria as a sixth factor. Thus, there is no
genuine consensus within the health care community as to what components comprise metabolic
syndrome (Guize et al., 2007). These varying definitions make comparing studies difficult and
add confusion when diagnosing metabolic syndrome. Table 1.1 presents the diagnostic criteria
for metabolic syndrome from these four organizations.
Three of five diagnostic criteria or markers are necessary to make the diagnosis of
metabolic syndrome using the NCEP-R definition. Treatment should target modifiable risk
factors in an effort to place the patient outside the diagnostic criteria.

Table 1.1
Comparison of ATP III, NCEP-R, IDF, and WHO Diagnostic Criteria for Metabolic Syndrome
Blood
Organization Waist Circumference
Triglycerides
HDL Cholesterol
Pressure
Men >102 cm
Men & Women Men < 40 mg/dl
SBP >/= 130
Women > 88 cm
>/= 150
Women < 50 mg/dl DBP >/= 85
ATP III
Men >102 cm
Women > 88 cm
NCEP-R

Men >94 cm
Women > 80 cm
IDF

Men & Women
>/= 150,
or
Treatment for
elevated
triglycerides
Men & Women
>/= 150,
or
Treatment for
elevated
triglycerides

Fasting Glucose
Glucose >/= 110

Diagnostic
Criteria
Three of the
five

Men < 40 mg/dl
Women < 50 mg/dl
or
Treatment for low
HDL

SBP >/= 130
DBP >/= 85
or
Treatment for
HTN

Glucose >/= 100
or
Treatment for
elevated glucose

Three of the
five

Men < 40 mg/dl
Women < 50 mg/dl
or
Treatment for low
HDL

SBP >/= 130
DBP >/= 85
or
Treatment for
HTN

Glucose >/= 100
or
Diagnosis of
diabetes

Presence of
abdominal
obesity and
two of the
remaining four

BMI > 30 kg/m2 or
Waist-to-hip ratio
Men > 0.90,
Women > 0.85

Men & Women Men < 35 mg/dl
BP >/=
Diabetes or
Fasting
Women < 39 mg/dl 140/90
Impaired fasting
>/= 150,
glucose or
or
glucose or
Insulin
WHO
Impaired glucose
resistant plus
Treatment for
tolerance test
two additional
elevated
triglycerides
criteria
*WHO criteria also include as a sixth criteria – Microalbuminuria > 30 mg albumin/g creatinine
From: “All-cause Mortality Associated with Specific Combinations of the Metabolic Syndrome According to Recent Definitions,” by
L. Guize, F. Thomas, B Pannier, K. Bean, B. Jego, & A. Bentos, (2007), Diabetes Care, 30, 2382.
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Ideally treatment should begin prior to a diagnosis of hypertension and/or
diabetes. Dietary interventions to reduce caloric intake and thereby reducing circulating
plasma glucose levels and waist circumference should be undertaken as early as possible.
For individuals with elevated blood pressure and/or hypertension, dietary salt reduction to
help reduce or prevent hypertension is an excellent initial intervention. Aerobic exercise
three to five times a week for 30 to 60 minutes has been shown to increase HDL, as well
as reduce circulating plasma glucose levels, triglycerides, and minimally reduce LDL
cholesterol (Carroll & Dudfield, 2004).
Purpose
The purpose of this project was to identify the effects of an intensive dietary and
exercise program on patients with metabolic syndrome. Specifically, the project was to
examined the effects of the program on waist circumference, blood pressure, HDL
cholesterol, triglycerides, and fasting glucose.
Definition of Terms
Metabolic syndrome. For the purposes of this project, the diagnosis of metabolic
syndrome was made based on the NCEP-R definition, that is, the presence of three or
more of the five diagnostic criteria (see Table 1.1).
Intensive dietary program. For the purposes of this project, a dietary plan was
designed for each study participant. It was designed to provide flexibility and be
constructed based on Mediterranean style diet principles. The dietitian provided
information on frequency of consumption of foods in specific food groups, serving sizes,
and number of servings. Suggested meal and snack patterns and food lists were
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determined for each participant based on local, ethnic, and personal preferences, as well
as socioeconomic constraints.
Mediterranean style diet. For the purposes of this project, the Mediterranean style
diet was defined as a diet consisting of a large amount of plant foods (i.e. fruits,
vegetables, nuts, and beans), minimal amounts of processed foods, a low to moderate
quantity of dairy products and less than four eggs per week. A limited amount of red
meat was recommended. Wine with meals in a low to moderate amount was acceptable.
Fresh fruit was recommended as a desert rather than concentrated sugars.
Intensive exercise program. For the purposes of this project, the intensive exercise
program is defined as a minimum of 30 to 60 minutes of exercise conducted at a
moderate level. The exercise can be dispersed throughout the day in no less than 10
minute segments. Individuals was urged to exercise at least three and preferably five days
a week.
Moderate physical activity. For the purposes of this project, moderate physical
activity is defined as walking briskly about 3 ½ miles per hour, hiking, gardening/yard
work, dancing, playing golf while walking and carrying clubs, bicycling at less than 10
miles per hour, and weight training.

5

Chapter Two: Review of Literature
This chapter contains an overview of the search strategies used for identification
and retrieval of the evidence. This was followed by a brief overview of cardiovascular
disease and a review of the evidence with respect to the effects of metabolic syndrome on
cardiovascular disease. A discussion of the relationship between socioeconomic position
and metabolic syndrome was followed by a synthesis of the evidence for nonpharmacologic interventions, the Mediterranean style diet and exercise.
Search Strategies
A systematic search of CINAHL, Medline, ProQuest, and the Cochrane Library
was conducted for the period January 2000 through March 2008 using the key words
metabolic syndrome or syndrome X. A search of Medline for meta-analyses published in
the English language returned a total of 10 items. When this search was further restricted
to diet or dietary and metabolic syndrome or syndrome X, three items were returned. A
search of the Cochrane Library database with these same parameters returned one
Cochrane Review.
The ProQuest search, limited to full text documents published in scholarly peerreviewed journals returned a total of 1641 items. When the search was limited by Top
Journals instead of Scholarly Journals the total number of items was reduced to 504. A
search of the Cochrane Library database returned 234 clinical trials.
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After accounting for duplications of resources across databases, a total of 5
systematic reviews and meta-analyses were reviewed. A total of 15 studies and additional
articles were also reviewed.
Cardiovascular Disease: An Overview
The U.S. Department of Health and Human Services (USDHHS, 2005) identified
heart disease and stroke as the principle components of cardiovascular disease. Heart
disease is the leading cause of death in both men and women in the United States and
stroke is the third leading cause of death. These two components of cardiovascular
disease account for nearly 930,000 American deaths each year (USDHHS, 2005). This is
almost 40% of all deaths and amounts to approximately one death every 33 seconds. The
burden of heart disease and stroke would be lessened considerably if the major risk
factors were reduced. These risk factors include high blood pressure, high cholesterol,
diabetes, physical inactivity, poor nutrition, and tobacco use.
In 2005 more than $394 billion was the projected cost of heart disease and stroke.
This includes $152 billion in lost productivity and $242 billion in health care
expenditures. Hypertension was responsible for an additional $60 billion in health care
spending in 2005 (USDHHS, 2005). A 21% decline in coronary heart disease, a 37%
decline in stroke, and a 25% decline in cardiovascular deaths would result from a
reduction of systolic blood pressure by 12 – 13 mmHg maintained over a 4 year period
(USDHHS, 2005).
Metabolic Syndrome and Cardiovascular Disease
Metabolic syndrome increases the risk of diabetes and cardiovascular disease
even in the absence of diabetes. Gami et al. (2007), in their systematic review and meta-
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analysis, identified 4,198 articles and determined that 104 were potentially relevant to
their question of the association between metabolic syndrome and cardiovascular events.
Of these, 67 were either cross-sectional designs or contained no data with reference to
metabolic syndrome or cardiovascular outcomes and one study was rejected because it
had the identical study cohort as a previously published study. This left a total of 36
articles to be included in the analysis. Diagnostic criteria varied between studies and
included WHO, NCEP-R, ATP III, as well as others which were not defined.
The outcomes of interest in this review were CV event, CHD event, CV death,
CHD death, and death (Gami et al., 2007). After ensuring heterogeneity between the
studies, the relative risk (RR) for the five outcomes was determined to be 1.60 to 2.18 (CI
1.28-2.01 and 1.63-2.93 respectively). The RR for cardiovascular events and death were
significantly different between those studies that employed the WHO and NCEP criteria
as compared to the other criteria. The large inconsistencies between the findings of
studies that use the WHO criteria and the studies that use the NCEP criteria could not be
explained merely by the use of different obesity metrics (see Table 2.1).
Gami et al. (2007) also found that the evidence, drawn from a significant number
of longitudinal studies, which included 172,573 people, indicated a significant increase in
the risk of cardiovascular events and death in people with metabolic syndrome and that
cardiovascular risk was a third higher for women with metabolic syndrome than for men.
The authors determined that use of the WHO criteria was more precise in predicting
cardiovascular events and death than the ATP III criteria. The substitution of BMI (body
mass index) for other measures of obesity did not adversely affect the results.
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Table 2.1
Relative Risk and Confidence Interval by Outcome in the Gami et al. Systematic Review
Outcome

Studies n

RR

95% CI

CV event

11

2.18

1.63-2.93

CHD event

18

1.65

1.37-1.99

CV death

10

1.91

1.47-2.49

CHD death

7

1.60

1.28-2.01

Death

12

1.60

1.37-1.92

From: “Metabolic syndrome and risk of incident cardiovascular events and death: A
systematic review and meta-analysis of longitudinal studies,” A. Gami, B. Witt, D.
Howard, P. Erwin, L. Gami, V. Somers, et al. (2007). Journal of the American College of
Cardiology, 49, 409.
In contrast to the findings of Gami et al. (2007), Lorenzo, Williams, Hunt, and
Haffner (2007) found equal effectiveness of the IDF, ATP III, and WHO diagnostic
criteria in predicting CVD in their secondary analysis of data from the San Antonio Heart
Study. This was a 12-year longitudinal study of 2941 individuals between the ages of 25
and 64. The researchers hypothesized that the combination of metabolic syndrome and
age (equal to or greater than 45 for men; 55 for women) could be used as a good marker
for cardiovascular disease (CVD) risk. They also postulated that metabolic syndrome plus
impaired fasting glucose (IFG) would be a better predictor of diabetes than either
parameter alone. The researchers applied the ATP III, IDF, and WHO diagnostic criteria
for metabolic syndrome. The predictive value of metabolic syndrome alone was then
compared to the predictive value of the Framingham 10-year risk assessment as a means
to predict CVD. The American Diabetes Association 2003 criterion for diagnosis of
diabetes was used (Gami et al. (2007). The development of CVD was assessed in 2,559
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of the 2,941 study participants; diabetes was assessed in 1,709 of the 2,459 non-diabetic
individuals in the original study.
New onset CVD was diagnosed in 93 (8.5%) men and 63 women (4.3%) for a
combined incidence of 6.1% (Lorenzo et al, 2007). Metabolic syndrome was not
predictive of new CVD events in individuals with existing coronary heart disease (CHD)
and/or CHD risk equivalents. In individuals who did not have CHD or CHD risk
equivalents the odds ratios (OR) were similar when either the ATP III, WHO, or IDF
criteria was used (see Table 2.2). Sensitivity was higher for the IDF criteria.
Table 2.2
Metabolic Syndrome Definition Predictive of Cardiovascular Disease by Definition in the
San Antonio Heart Study
Odds Ratio (OR)

95% Confidence Interval
(CI)

ATP III

2.00

1.33 – 3.01

IDF

1.69

1.13 – 2.54

WHO

1.73

1.12 – 2.67

Definition

From: “The National Cholesterol Education Program-Adult Treatment Panel III,
International Diabetes Federation, and World Health Organization definitions of the
metabolic syndrome as predictors of incident cardiovascular disease and diabetes,” C.
Lorenzo, K. Williams, K. Hunt, & S. Hafner. (2007). Diabetes Care, 30, 9.
When metabolic syndrome and age were considerated together this increased the
ability to predict CVD (see Table 2.3). CVD risk predicted by metabolic syndrome alone
had inferior predictive value for CVD risk when compared to the predictive value of the
Framingham score.
Diabetes developed in 11.4% of the subjects. The predictive value of developing
diabetes by the presence of metabolic syndrome alone was similar to the predictive value
using the two hour glucose tolerance test value. All definitions had similar predictive
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value for diabetes, except again IDF had increased sensitivity. Lorenzo et al. (2007)
determined that an improved risk assessment for diabetes may be better accomplished by
considering all individuals with glucose intolerance and or metabolic syndrome at a high
risk for the development of diabetes.
Table 2.3
Metabolic Syndrome Plus Age Predictive of Cardiovascular Disease by Definition: From
the San Antonio Heart Study
Definition

Men Age > 45

Women Age > 55

OR

95% CI

OR

95% CI

ATP III

9.25

4.85 – 17.7

4.98

2.08 – 12.0

IDF

9.55

5.09 – 17.9

4.40

1.92 – 10.1

WHO

6.47

3.30 – 12.7

5.85

2.28 – 15.0

From: “The National Cholesterol Education Program-Adult Treatment Panel III,
International Diabetes Federation, and World Health Organization definitions of the
metabolic syndrome as predictors of incident cardiovascular disease and diabetes,” C.
Lorenzo, K. Williams, K. Hunt, & S. Hafner. (2007). Diabetes Care, 30, 8.
A limitation of the study was that the CVD data were obtained by questionnaire
and review of death certificates. The confidence intervals were wide when predicting
CVD risk in women.
Simons, Simons, Friedlander, and McCallum (2007) conducted a 16 year cohort
study with 2805 individuals over the age of 60 in Dubbo, New South Wales, Australia to
determine if a diagnosis of the metabolic syndrome provided additional predictive value
of cardiovascular disease and total mortality in the elderly above that normally associated
with the known risk factors. The researchers used the NCEP-R definition of metabolic
syndrome with the exception that BMI was used instead of waist circumference, with
29.3 kg/m2 as a reference point for central obesity. Hospitalization and death records
were continuously monitored and mail surveys were conducted every 2 years.
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Greater than 95% of the surviving participants were traceable during the last
survey (Simons et al., 2007). A total of 384 men (31%) and 536 women (34%) were
diagnosed with metabolic syndrome. Of these, 211 men (55%) and 259 women (48%)
had CHD, 269 men (18%) and 91 women (17%) had ischemic stroke, and total mortality
was for men was 256 (67%) and for women 275 (51%). All outcomes were more frequent
when metabolic syndrome was present in all age groups except for those > 80 year-ofage, but this group was also the fewest in number (see Table 2.4). After controlling for
age, metabolic syndrome was a significant predictor of CHD in both men and women.
Simons et al. (2007) concluded that a diagnosis of metabolic syndrome in older people is
a good predictor of coronary heart disease, stroke, and total mortality over and above any
other risk factors.
Metabolic Syndrome and Socioeconomic Position
A review of studies reflecting approximately 194,000 individuals in the United
States, Senegal, and Europe literature found an inverse relationship between smoking
prevalence, a health behavior, and socioeconomic status (SES) (Kaplan & Keil, 1993). In
1987 the prevalence of smoking was 35.7% among non-high school graduates and 16.3%
among college graduates. Decreases in smoking from 1974 to 1985 were greater among
college graduates (10.1%) than those with less than a high school education (1.1%).
Kaplan and Keil (1993) also found an inverse relation between SES and high blood
pressure.
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Table 2.4
Event Prediction by Number of Component Variables of Metabolic Syndrome in the New
South Wales Study
MEN

Women

Number of
components

0

CHD

Stroke

Mortality

CHD

Stroke

Mortality

1.00

1.00

1.00

1.00

1.00

1.00

1.84
0.94
1.41
1.55
2.14
1.03
(1.12 –
(0.50 –
(0.96 –
(0.93 –
(0.92 –
(0.70 –
3.01)
1.78)
2.06)
2.59)
4.95)
1.53)
1.85
1.07
1.50
1.97
1.97
1.26
2
(1.13 –
(0.57 –
(1.02 –
(1.18 –
(0.84 –
(0.85 –
3.05)
2.01)
2.20)
3.28)
4.64)
1.87)
2.83
1.01
2.15
2.42
2.12
1.23
3
(1.71 –
(0.51 –
(1.45 –
(1.45 –
(0.90 –
(0.82 –
5.04)
2.00)
3.19)
4.04)
5.03)
1.84)
3.00
1.78
2.14
3.68
3.84
2.06
4 or 5
(1.79 –
(0.91 –
(1.42 –
(2.19 –
(1.61 –
(1.37 –
5.04)
3.48)
3.23)
6.20)
9.15)
3.11)
Note. Values are hazard ratios and 95% confidence intervals.
From: “Does a diagnosis of the metabolic syndrome provide additional prediction of
cardiovascular disease and total mortality in the elderly? The Dubbo Study,” L. Simons,
J. Simons, Y. Friedlander, & J. McCallum, (2007). Medical Journal of Australia, 186,
402.
1

Loucks, Rehkopf, Thurston, and Kawachi (2006) found that socioeconomic
position (SEP) is associated with metabolic syndrome and that the association differs by
gender and ethnicity (see Table 2.5). There were a total of 11,107 participants 25 years of
age or older with 5,341 men and 5,766 women. The prevalence of metabolic syndrome in
this sample was 29.9% (95% CI, 27.7 – 323) in men and 28.4% (95% CI, 26.2 – 30.8) in
women.

Table 2.5
Odds Ratio and Confidence Intervals for Education Level and Metabolic Syndrome Stratified by Covariant in NHANES III
Women
Years of Education
< 12 Years
12 Years
> 12 Years
n=2166
n=1941
n=1659
Ethnicity
Model Adjustment
OR
95% CI
OR
95% CI
OR

All
White
n=718, 1012, 952
Black
n=504, 553, 440
Mexican-American
n=849, 323, 186
Men
All

Age, ethnicity

2.25

1.74-2.91

1.67

1.31-2.12

1.0

Age, ethnicity, health behaviors

1.85

1.42-2.41

1.54

1.21-1.97

1.0

Age, ethnicity, health behaviors, parity

1.77

1.39-2.24

1.46

1.16-1.84

1.0

1.68

1.26-2.23

1.35

1.03-1.77

1.0

1.10

0.68-1.78

1.42

1.06-1.90

1.0

1.66

1.04-2.64

1.36

0.95-1.94

1.0

Age, ethnicity, health behaviors, parity
Age, ethnicity, health behaviors, parity
Age, ethnicity, health behaviors, parity

n=2276

n=1440

n=1659

Age, ethnicity

1.33

1.04-1.70

1.40

1.13-1.77

1.0

Age, ethnicity, health behaviors

1.27

0.97-1.66

1.32

1.04-1.68

1.0

White
Age, ethnicity, health behaviors
1.20
0.87-1.66
1.37
1.04-1.68
1.0
n=738, 700, 979
Black
Age, ethnicity, health behaviors
1.01
0.63-1.62
1.02
0.69-1.51
1.0
n=515, 423, 322
Mexican-American
Age, ethnicity, health behaviors
0.75
0.54-1.05
0.87
0.53-1.45
1.0
n =52, 274, 250
Note. Health behaviors alcohol consumption, smoking, physical activity, and diet:
From: “Socioeconomic disparities in metabolic syndrome differ by gender: Evidence from NHANES III,” E. Loucks, D. Rehkopf, C.
Thurston, & I. Kawachi, (2007). Annals of Epidemiology, 17, 23.
13
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Less than 12 years of education was statistically significantly associated with an
increased risk of metabolic syndrome in both men (OR 1.33;95 % CI 1.04 – 1.70) and
women (OR 2.25; 95 % CI 1.74 – 2.91) (Loucks et al., 2006). When adjusted for health
behaviors (dietary consumption of total fat, carbohydrates, fiber, physical activity,
smoking, and alcohol consumption) the relationship remained significant for women but
not for men.
Santos, Ebrahim, and Barros (2008) found similar results when investigating
socio-economic and gender status and metabolic syndrome in adults in Porto, Portugal.
There were 1962 participants aged 40 or older (1207 women and 755 men). The
prevalence of metabolic syndrome in the study population was 22.0% using ATP III
criteria and 31.8% when IDF criteria were applied. They found that metabolic syndrome
was more prevalent in women verses men using both definitions, All five of the
diagnostic criteria were present in 3.1% of the women and 0.6% of the men. The odds of
metabolic syndrome in women increased with age and decreased with education level and
social class. In men metabolic syndrome was not associated with any socio-economic
indicators. The researchers hypothesized that an unfavorable socio-economic
environment increases the risk of metabolic syndrome in a gender-specific manner and
that men in lower socio-economic strata are more likely to have more physically
demanding occupations which would increase their total caloric expenditure (Santos et
al., 2008). This would be a protective mechanism for men that would prevent them from
developing metabolic syndrome.
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Nonpharmacologic Measures for Treatment of Metabolic Syndrome
Lifestyle modification is a primary treatment modality for all of the parameters
that make up metabolic syndrome. Such modifications include changes in both dietary
and exercise behaviors.
Diet. Food consumption patterns may be related to socioeconomic status (Loucks
et al., 2008). Energy dense foods are predominantly composed of sugars, fats, or refined
grains are cheaper and individuals with low incomes may preferentially purchase these
foods resulting in a higher caloric intake and increased risk of obesity. Simple changes in
diet may decrease the incidence of metabolic syndrome. The Mediterranean style diet has
been discussed as one way to facilitate a healthier life style.
The Mediterranean style diet consists of a large amount of plant foods (i.e. fruits,
vegetables, nuts, and beans), minimal amounts of processed foods, fresh fruit as a desert
rather than concentrated sugars, low to moderated amounts of dairy products (i.e. yogurt
and cheese), less than four eggs per week, low amounts of red meat, and wine with meals
in a low to moderated amount (Serra-Majem, Roman, & Estruch, 2006). There is, in
general, a higher incidence of cardiovascular disease in the United States and northern
European countries when compared with countries of the Mediterranean basin (France,
Spain, Greece, and Italy). This difference in incidence has led to investigation of the
association of diet to cardiovascular disease.
Serra-Majem et al. (2006) identified 55 clinical trials investigating this
relationship, of which 12 were excluded due to language, the fact that the intervention
was limited to one food product, or for methodological weaknesses, leaving 43 studies
for the systematic review. The authors identified weaknesses in the review of the
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evidence on the use of the Mediterranean style diet. The evidence is derived primarily
from observational studies, personal reviews, and several studies were excluded from
previous reviews of the Mediterranean style diet (Serra-Majem et al., 2006). These
excluded studies were critical of, or did not support the use of, Mediterranean style diet
raising the possibility of bias in the other analysis. In their opinion several of the
excluded studies were well conducted and their outcomes valid.
Belahsen and Rguibi (2006) found that there is increasing evidence that lifestyle
changes which incorporate a decrease in activity, an increase in caloric intake, and
adopting a more western style diet may be contributing to the increase in obesity and
diabetes in southern Mediterranean countries. They postulate that by the year 2020 71%
of ischemic heart disease deaths, 75% of stroke deaths, and 70% of diabetes related
deaths will occur in developing countries.
Belahsen and Rguibi (2006) determined that an increase in cardiovascular risk
factors and rates of obesity in this area is linked to an increasingly sedentary way of life.
There has been a decrease in physical activity and leisure time is spent watching more
hours of TV per week. There is also a corresponding increase in the utilization of vehicles
and activity saving appliances. The Jordan Global School-Based Student Health Survey
showed that 44.6% of men and 45.2% of women did not walk or ride a bike. A study in
2002 among Moroccan women over 15 years of age found that physical inactivity
appeared to play a crucial role in the development of body fat and may be a risk factor for
development of metabolic syndrome (Belahsen & Rguibi, 2006).
There has been significant progress in raising food consumption per person and
this increased availability of food has created a shift in what had been the standard diet in
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this area of the Mediterranean. This shift in diet has created away from barley as the
primary grain source and an increased consumption of wheat and livestock products.
There is also a shift towards the use of vegetable oils for a dietary fat source. Belahsen
and Rguibi (2006) believe that the “important point is that there has been a remarkable
increase in the intake of dietary fats” (p. 1133). There has also been an approximately
1000 kcal per captia per day increase from 1965 – 2000, which exceeds the per caput
energy requirements.
This shift from the traditional Mediterranean style diet to a more western
industrialized diet and a more sedentary life style could explain the increases in obesity
seen in this region (see Table 2.6). A move from a more rural to urban population has
also been accompanied by an increase in obesity, hypertension, diabetes, and
hypercholesterolaemia (Belahsen & Rguibi, 2006).
The Mediterranean dietary pattern emphasizes that fat consumption should be
between 30 and 40% of an individual’s daily energy intake (Giugliano & Esposito, 2008).
These fats should primarily come from monounsaturated fatty acids. There is not a single
Mediterranean style diet as the dietary habits vary from country to country, but the
primary characteristics of this dietary style include large amounts of plant food, olive oil
as the principle source of dietary fat, fish and poultry in moderation, little red meat, and a
moderate amount of alcohol usually with meals in the form of wine.
In a review of the European Prospective Investigation into Cancer and Nutrition
(EPIC) study of 17,238 women and 10,589 men who were not obese at baseline,
individuals with a high adherence to Mediterranean style diet had a significantly lower
risk of being obese (OR 0.69, 95% CI 0.54-0.89 for women; OR 0.68, CI 0.53-0.89 for

18
men) (Giugliano & Esposito, 2008). When a high consumption of olive oil (46g/day) was
compared with a lower consumption (6g/day) there was no association with increased
weight. An inverse relationship was also observed between adherence to the
Mediterranean style diet and increases in insulin resistance. Additionally, a crosssectional analysis of 2,834 individuals in the Framingham Offspring Study showed that
whole grain and cereal fiber intakes were associated with a 38% lower risk of
development of metabolic syndrome (Giugliano & Esposito, 2008).
Table 2.6
Calorie Consumption and Obesity in Southern Mediterranean Countries
Energy Consumption

Male Obesity %

Female Obesity %

Country
1965-1967

2000-2002

2002

2005

2002

2005

Algeria

1740

2990

4.52

5.18

11.91

13.44

Egypt

2287

3318

21.98

21.98

39.34

45.46

Jordan

2152

2834

19.62

19.62

40.19

35.62

Libya

2061

3324

10.74

11.45

21.13

22.52

Tunisia

2323

3272

7.74

7.74

28.78

30.2

Note. Energy consumption in kcal per capita per day; obesity = BMI > 30 kgm-2
From: “Population health and Mediterranean diet in southern Mediterranean countries,”
R. Belahsen, & M. Rguibi, (2006). Public Health Nutrition, 9, 1133.

The Seventh Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (JNC 7) recommends lifestyle
modification by all individuals and adopting healthy lifestyles (USDHHS, 2003).
Lifestyle modification is an indispensable part of the management of those with
hypertension. In individuals who are overweight or obese major lifestyle modifications
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have been shown to be effective in reducing blood pressure (USDHHS, 2003). The JNC 7
also recommends the use of Dietary Approaches to Stop Hypertension (DASH) eating
plan (USDHHS, 2003). The DASH diet is rich in potassium and calcium, but
recommends a restriction on dietary sodium, an increase in physical activity, and
moderate alcohol consumption. The lifestyle modifications that reduce BP also enhance
antihypertensive drug efficacy and this synergistic approach decreases cardiovascular
risk. A 1,600 mg sodium DASH diet plan has similar outcomes in blood pressure
reduction to single drug therapy. When combinations of two or more lifestyle
modifications are initiated they can achieve even more blood pressure reduction
(USDHHS, 2003).
Exercise. Another risk factor for metabolic syndrome that is suitable for
intervention in individuals in all socioeconomic circumstance is exercise. Carroll and
Dudfield (2004) performed a review of literature to determine the effects of exercise on
the metabolic syndrome, insulin resistance, abdominal adipose tissue accumulation,
impaired glucose regulation, atherogenic dyslipidemia, and hypertension.
Nine months of exercise training alone increases maximal aerobic capacity by
14% in obese middle-aged and older men without a significant change in bodyweight,
oral glucose tolerance response, lipids, or blood pressure. Hypocaloric diets and body
weight reduction also improve insulin resistance. When dietary changes or exercise
induce an 8% weight loss, insulin sensitivity improves up to 60% (Carroll & Dudfield,
2004).
A regular exercise program conducted three to five times a week for 30 to 60
minutes at lower intensity than what is typical for cardiovascular fitness has shown
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metabolic benefits (Carroll & Dudfield, 2004). Aerobic exercise and dietary studies
found that exercise lowers blood pressure and improves glucose metabolism in obese,
sedentary insulin-resistant men. This intervention reduced body fat by 21% and produced
a 9% overall reduction in weight (Carroll & Dudfield, 2004). In sedentary overweight
European and South Asian males and females exercise training consisting of three halfhour sessions of walking or jogging and one supervised aerobic circuit training session
produced no weight change, but insulin sensitivity was improved by 40% (Carroll &
Dudfield, 2004).
When blood glucose levels are higher than normal, but less than a diagnostic level
for diabetes it is referred to as impaired glucose regulation. Carroll and Dudfield, (2004),
reviewed the 1999 Obesity Education Initiative expert panel. This panel reviewed five
RCTs that showed weight loss produced by lifestyle intervention improved fasting
glucose levels when compared to controls. They reviewed three additional RCTs which
were conducted in various countries with various ethnic groups. The review of these
RCTs confirmed that regular exercise can prevent or delay the onset of type II diabetes in
high risk groups who suffer from impaired fasting glucose.
Individuals with low levels of HDL cholesterol, hypertriglyceridemia, and a high
level of small dense low density lipoprotein (LDL) have athrogenic dyslipidemia. This
cluster of dyslipidemic markers has been associated with increases in CVD. The literature
search revealed 65 RCTs investigating exercise and lipoprotein-lipids. Only 15 of the
original 65 articles were analyzed (Carroll & Dudfield, 2004). The 15 clinical trials
incorporated 20 study groups. Ten study groups were composed of male only
participants, six groups were mixed male and female, and 4 groups were female only.
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There were 1007 total participants with 587 randomized to the exercise intervention
groups and 420 to control groups. The duration of the exercise interventions ranged from
12 to 52 weeks with a median of 39 weeks. Exercise frequency was three to five times a
week with the duration being 30 to 60 minutes.
Body mass changes were reported in 12 of the 20 treatment groups and three
others reported changes in BMI (Carroll & Dudfield, 2004). The mean changes in body
mass in the exercise study groups ranged from between 1.5 and 1.9 kg; except that the
single 12 month program produced a 4.0 kg change. All 20 study groups examined HDLC response to exercise training alone compared with a control group with no exercise.
HDL-C analysis showed an increase of 0.046 mmol/L (95% CI 0.27 – 0.65mmol/L,
p<0.0001) (Carroll & Dudfield, 2004). Triglycerides were evaluated in 19 of the 20
groups. There was a mean reduction of triglycerides of -0.21 mmol/L (95% CI of -0.29 to
-0.14, p<0.0001) (Carroll & Dudfield, 2004). The results of this analysis revealed that
moderate to moderately vigorous regular supervised exercise training is associated with
modest improvements in HDL and TG levels in a middle-age and older overweight or
obese adults (see Table 2.7).
Hypertension is a well established metabolic disorder and approximately 25 to
33% of normal weight hypertensive individuals also suffer from insulin resistance. A
three to nine percent reduction in weight is associated with a mean reduction of systolic
and diastolic blood pressure of approximately 3.0mm Hg. Exercise training reduces blood
pressure in approximately 75 – 85% of the groups with a weighted mean reduction of
10.6/8.2 mm Hg. These blood pressure reductions were noted as early as 10 weeks after
commencement of the exercise program. (Carroll & Dudfield, 2004).
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Table 2.7
Effect Size of Exercise on Lipoprotein Levels in Overweight/Obese Sedentary Men and
Women
Lipoprotein
Weighted mean difference method
Standardized mean difference
Particle Type
method
Effect
95% CI
p-value
Effect
95% CI
p-value
Size
Size
Total
-0.05
-0.178,
0.50
-0.05
-0.14,
0.29
Cholesterol
0.08
0.04
LDL-C
0.001
-0.116,
0.98
0.005
-0.07,
0.89
0.12
0.06
HDL-C
0.254
0.14,
<0.0001
0.046
0.27,
<0.0001
0.37
0.065
Triglycerides
-0.326
-0.46, <0.0001
-0.21
-0.286, - <0.0001
0.21
0.14
From: “What is the relationship between exercise and metabolic abnormalities?”S
Carroll, & M. Dudfield, (2004). Sports Medicine, 34, 339
This chapter has been a review of literature on the prevalence and cost of
cardiovascular disease in the United States and the cause and effect relationship of
metabolic syndrome and cardiovascular disease. The effect of socioeconomic position
has on the prevalence of metabolic syndrome was reviewed, as well as the
nonpharmacologic measures that can be employed to combat metabolic syndrome.
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Chapter Three: Methodology
This chapter includes a description of the design, setting and sample for the
project and the methods and procedures for the study. This is followed by a discussion of
the feasibility, data analysis plan and protection of human subjects.
Study Design
This project was the implementation of an evidence-based practice change
incorporating an intensive dietary and exercise program for patients with metabolic
syndrome and evaluation of the effect of that change on lipoproteins HDL-C and
triglycerides, serum glucose levels, blood pressure, and waist circumference. This study
was a one-group before-and-after design, with baseline data obtained on patients prior to
the practice change. The study ran for six months.
Setting and Sample
The setting for the study was an internal medicine practice in a large city in the
Southeastern United States. The practice has one physician and one nurse practitioner.
There are approximately 3,206 patients in this practice 20% of whom would meet the
inclusion criteria.
Criteria for inclusion in the study were: males and females ages 18 to 65 who met
the ATP III diagnostic criteria for metabolic syndrome. Exclusion criteria were:
individuals diagnosed with diabetes and those with, dietary limitations due to religious or
medical conditions, or who were unable to perform the moderate exercise portion of the
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study due to preexisting medical conditions. Participants, who were diagnosed with
diabetes after the start of the study, were eligible to complete the study and be included in
the final analysis.
Procedures
Participants were recruited for 30 days from the practice location. All patients
who met the inclusion criteria were considered eligible for the study. Patients who had a
current diagnosis of metabolic syndrome and who consented to be in the study were reevaluated by ATP III criteria and if they met the definition were eligible for participation.
Other individuals who did not have a diagnosis of metabolic syndrome, but during the
normal course of their appointments appeared to meet the criteria were evaluated by ATP
III criteria and if diagnosed with metabolic syndrome they were given the option of
participation during that office visit. Prior to agreeing to participate all individuals were
counseled by the primary investigator regarding the diet and exercise programs.
Practice change. A food consumption frequency analysis was performed on all
patients entering the study. A food scoring system (FSS) was utilized to provide
information on frequency of consumption of foods within specific food groups.
Dietary counseling was provided to each participant at the time of the initial and
each subsequent visit. The diet and exercise programs were furnished as an
individualized folder/booklet. These booklets include exercise and dietary logs as well as
other educational materials. Handouts/pamphlet on diet and exercise recipe booklet,
sample shopping list, invitation to E-mail newsletter was provided at the initial meeting.
The participants’ exercise and dietary logs were reviewed at the visits on day 30, day 90,
and day180.
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The exercise recommendations were based on the data reviewed earlier as well as
the recommendations of the American Heart Association and the US Department of
Agriculture food guide pyramid. All study participants had their current exercise
practices evaluated prior to beginning the study. Each participant was then counseled by
the primary investigator on an unsupervised exercise program. Weight training was also
encouraged. A written exercise program was provided to each participant at the initial
visit in addition to the exercise log.
Evaluation Plan
Two medical assistants were trained in all aspects of data collection and they were
the only individuals except the primary investigator and a master’s level dietetic intern to
collect data. A complete history and physical examination was performed at the initial
visit. The history included a review of social, demographic, personal, and family medical
history including current dietary habits and physical activity, tobacco use, and alcohol
intake. The physical exam consisted of a head-to-toe physical and included
anthropometric measurements (height, weight and calculation of BMI), waist
circumference, and blood pressure. Laboratory studies included lipoprotein and glucose
levels.
Subsequent visits occurred at 30, 90, and 180 days. Evaluation included updating
the medical history, including smoking and alcohol intake; measuring lipoproteins,
fasting blood glucose, blood pressure, waist circumference, anthropometrics; analysis of
dietary and exercise logs; and individual counseling based on these measurements.
Anthropometric measurements. Anthropometrics were obtained at each visit with
the participant in light clothing and barefoot. Body weight was measured to the nearest ¼
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pound as measured on a standard standing office scale. Height was measured at the initial
visit to the nearest 1/8th inch using a stadiometer. BMI was calculated using a standard
BMI chart.
Waist circumference. Waist circumference was measured at each visit with the
subject standing erect with the clothing from around the waist removed. A flexible unstretchable tape was used, avoiding exertion of pressure on the tissue. The waist
circumference was measured midway between the lower limit of the rib cage and the
iliac crest with the tape level and recorded to the nearest millimeter using the same tape
measure at each visit.
Blood pressure. Blood pressure was measured at each visit using U.S. Department
of Health and Human Services (JNC 7) (2003) guidelines. The ausculatory method with a
properly calibrated and validated instrument was used to measure blood pressure. The
subject was seated quietly for at least 5 minutes in a chair with both feet on the floor and
the arm supported at the heart level. An appropriate sized cuff with the bladder encircling
at least 80% of the arm was used. Two readings were taken at least five minutes apart and
the average of the two readings were used unless there was a difference in the systolic
blood pressure readings of more than 6 mmHg. If a third reading was necessary the
average of the two closest readings was used.
Lipoprotein levels. Fasting lipoprotein levels were measured at baseline, 90 days,
and 180days. Lipoprotein levels (total cholesterol, triglyceride, HDL-C, and LDL-C)
were evaluated using a Cholestech LDX Cholesterol Analyzer™. The reliability of the
analyzer was established per the manufactures instructions using the Cholestech optics
check and liquid controls. The optics check was conducted using the analyzer check
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cassette supplied with the unit. The optics check was conducted at a minimum once each
day before patient sampling, when the unit was moved, or when the unit was serviced.
The liquid controls were conducted at the beginning of each visit and if a different lot
number or new box of cassettes was opened. The blood sample required for this
evaluation was collected by finger stick.
Glucose. Fasting glucose levels were evaluated with an Accu-Chek Compact Plus
capillary glucose meter. This glucometer does not require calibration. Coding is
performed automatically when the test strip drum is placed in the glucometer. Control
testing, with the provided control solution, was performed as a minimum when the test
strip drum was replaced, if the meter was dropped, or if the control bottle symbol flashed
on the meter display. This did not require a second finger stick, since there was ample
blood from the finger stick performed for the lipoprotein analysis.
Exercise analysis. An exercise analysis was performed on all patients entering the
study. Each participant was then counseled by the primary investigator regarding the
exercise component. Participants were provided with written information regarding
exercise, an exercise log, encouraged to exercise at least three (ideally five) days per
week at a moderate level and to record their exercise on the exercise log. Exercise was
defined as additional time during the day separate from work or other normal daily
activities. The exercise component was evaluated at each visit. The exercise logs were
evaluated and exercise was categorized as none (0 days per week), minimal (1-2 days per
week), moderate (3-4 days per week), or maximal (more than 4 days a week). Exercise
was judged as compliant or noncompliant. Participants were judged to have been
compliant with the exercise component if their exercise averaged more than 135 minutes
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per week (45 minutes a day for a minimum of 3 days a week) and were compliant at least
13 of the 25 weeks of the study.
Dietary analysis. A food consumption analysis was performed on all patients
entering the study using a food scoring system (FSS). Each participant was then be
interviewed and counseled by the master’s level dietetic intern regarding the customized
Mediterranean style diet. This customized plan was based on age, gender, weight, height,
and physical activity and included suggested calories to be consumed each day, servings
of grains, beans, vegetables, fruits, dairy products, healthy fats, and meats. Written
information on the Mediterranean style diet was provided for each participant at the first
visit along with the dietary log. At each visit the dietary logs and the FSS were reviewed
to assess overall compliance as well as compliance within each food category/group. A
nutrient analysis was not conducted. The FSS provided a baseline description of the
participants’ diet and how it related to the recommended Mediterranean style diet. The
same FSS was used throughout the study to measure change and compliance over time.
The master’s level dietetic intern also evaluated the participants’ dietary changes as they
relate to the participants’ perception of their progress. This was developed as a critique of
the dietary portion of the project. A FFS was completed during the last visit and changes
in dietary patterns were assessed in relation to the initial FFS.
Practice Impact
Current staff members were trained on and are proficient in the use of the
materials to be used. A review of the material and the specific requirements of the study
was conducted. Staff members were briefed on confidentiality and the study guidelines.
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There was minimal fiscal impact on the practice setting. Initial participant
interviews coincided with previously arrange office visits. Follow-up visits were
conducted during non-office hours so as to not interfere with the operation of the clinic
and no reimbursement from insurance companies was sought. The medical assistants
agreed to participate without compensation for their time, but were reimbursed for fuel
and a meal was provided. The total cost of intervention supplies per participant was
estimated to be approximately $.0.15 per visit (see descriptions below). This cost was
borne by the practice. The total cost of miscellaneous supplies, copying, binding,
folders/booklets, and computer supplies did not exceed $300. During the implementation
period, this cost was borne by the primary investigator.
The Cholestech LDX Analyzer was available in the practice site and the cost of
each use was approximately $12 per cassette per visit. The cassettes for the cholesterol
analyzer are being donated by the Cholestech representative and purchased by the
primary investigator out of a grant from the University of North Florida, School of
Nursing. The cost of the one use lancing device is approximately $0.02 per patient per
visit. Miscellaneous supplies (cotton balls, alcohol wipes, gauze) cost approximately
$0.05 per participant per visit.
A new Accu-Chek Compact Plus capillary glucose meter was supplied by the
Accu-Chek representative at no cost. The cost of the test strips was approximately $0.95
per strip. The Accu-Chek representative also supplied the test strip drums and control
solution at no cost.
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Protection of Human Subjects
Prior to beginning recruitment of participants University of North Florida (UNF)
Institutional Review Board (IRB) approval was obtained. All institutional, state, and
federal regulations with respect to protection of human subjects were adhered too. If at
any time possible injury either physical or psychological to a participant was suspected
the action or inaction that could have caused the injury would have been immediately
corrected. No actual injuries occurred. The procedures outlined by the UNF IRB would
have been followed if required.
Protection of participant information was of paramount importance. After closing
recruitment participants were randomly assigned a study number and all collected data
was only linked to the study number. Any documents that linked a participants name or
other identifying data with their study number was maintained by the primary
investigator in a secured area. Any documents that would link a participants name with
their study number or other study data was destroyed as soon as possible after the study
was closed. Data collectors and researchers, other than the primary investigator, did not
have access to the raw data until the study was ended.
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Chapter Four: Results
This chapter provides a description of the sample and the results of the analysis
pertaining to outcomes. This is followed by a discussion of unintended consequences and
barriers encountered.
Subject Disposition
During the enrolment period fifteen (15) patients who met the inclusion criteria
agreed to participate in the study. The first meeting (baseline) was conducted one week
after the closing of the enrolment period. Twelve of the fifteen participants were present
at the first meeting and had baseline biometric measurements taken. The attrition of
participants continued throughout the study period. Ten of the participants who signed
consents did not complete the study. Five of the ten withdrew for unknown reasons, three
withdrew due to changing primary care physicians, and 2 withdrew due to the dietary
constraints. Figure 4.1 shows the disposition of subjects during the study period.
Sample
Five of the original fifteen participants completed the study. All were Caucasian,
three of the five were male with the youngest being 47 and the oldest being 55. Two were
female and their ages were 40 and 61. Table 4.1 shows the demographic information of
the five individuals who completed the study.
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Initial Consent Obtained N = 15
3 Individuals were not present at the initial
meeting. Reason Unknown.
Baseline Evaluation N = 12
1 Participant withdrew, change primary care
physicians.
Day 30 Evaluation N = 11

5 Participants withdrew, 2 withdrew
consent due to dietary constraints, 2
changed primary care physicians, and 1
reason unknown.

Day 90 Evaluation N = 6

1 Participant withdrew reason unknown.
Day 180 Evaluation N = 5

Figure 4.1. Disposition of Subjects

Table 4.1
Demographic Information for the Five Individuals Who Completed the Study
Data

Male

Female

Participant

3

2

Average Age

52

50.5

Current Tobacco Use

0

0

2

1

2

1

0

0

Currently Taking Hypertension
Medications
Currently Taking Dyslipidemia
Medications
History of Heart Disease
Metabolic Components

The data as it relates to the five metabolic disorders that comprise metabolic
syndrome (waist, glucose, blood pressure, HDL, and triglycerides) were only computed
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for participants who completed the study (see Table 4.2). Biometric measurements were
taken at baseline, day 30, day 90, and day 180 for waist, glucose, systolic blood pressure,
and diastolic blood pressure. Biometrics for HDL and triglycerides were taken at
baseline, day 90, and day 180. The data was analyzed using SPSS version 16.0. The
mean, standard deviation and significance level were obtained for all metabolic syndrome
components at baseline and were compared to day 180.
Table 4.2
Descriptive Statistics for Metabolic Syndrome Component at Baseline and Day 180
Baseline

Metabolic Syndrome
Component

Mean

Standard
Deviation

Day 180
Mean

Standard

Significanc
e

Deviation

120.90

24.79

115.10

22.86

p = 0.007

Glucose

100.80

22.90

98.40

7.30

p = 0.828

SBP

135.80

16.76

120.80

2.20

p = 0.108

DBP

85.60

5.32

71.20

6.38

p = 0.047

HDL

32.80

11.37

34.40

4.57

p = 0.327

Triglycerides

207.60

75.02

216.00

124.42

p = 0.840

3.67

0.58

3.00

1.41

4.00

1.41

4.00

1.41

Waist

Average Number
Components Males
Average Number
Components Females

* 95% Confidence Level and α 0.05
Waist. The average decrease in waist size from baseline to day 180 (5.8 cm ± 2.6
cm) was evaluated using paired t-test. There was a statistically significant change at the
95% confidence interval (p = 0.007) (see Figure 4.2).
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Figure 4.2. Average Waist Size of Participants from Baseline to Day 180
Glucose. The average decrease in glucose from baseline to day 180 (2.4 mg/dl ±
15.6 mg/dl) was evaluated using paired t-test. There was a non-statistically significant
change at the 95% confidence interval (p = 0.828) (see figure 4.3).

Figure 4.3. Average Glucose of Participants from Baseline to Day 180
Systolic Blood Pressure (SBP). The average decrease in SBP from baseline to day
180 (15.0 mmHg ± 11.78 mmHg) was evaluated using paired t-test. There was a non-
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statistically significant decrease in SBP at the 95% confidence interval (p = 0.108) (see
figure 4.4).

Figure 4.4. Average Systolic Blood Pressure of Participants from Baseline to Day 180
Diastolic Blood Pressure (DBP). The average decrease in DBP from baseline to
day 180 (14.4 mmHg ± 1.06 mmHg) was evaluated using paired t-test. There was a
statistically significant decrease in DBP at the 95% confidence interval (p = 0.047) (see
figure 4.5).

Figure 4.5. Average Diastolic Blood Pressure of Participants from Baseline to Day 180
High Density Lipoprotein (HDL). The average increase in HDL from baseline to
day 180 (1.6 mg/dl ± 1.16 mg/dl) was evaluated using paired t-test. There was a nonstatistically significant increase of HDL at the 95% confidence interval (p = 0.327) (see
figure 4.6).
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Figure 4.6. Average HDL Levels of Participants from Baseline to Day 180
Triglycerides. The average increase in triglycerides from baseline to day 180 (8.4
mg/dl ± 49.39 mg/dl) was evaluated using paired t-test. There was a non-statistically
significant increase of triglycerides at the 95% confidence interval (p = 0.084) (see figure
4.7).

Figure 4.7. Average Triglyceride Levels of Participants from Baseline to Day 180
Exercise and Diet
Exercise. The exercise segment of the intervention was evaluated on a compliant
noncompliant basis. As previously stated the participants were encouraged to exercise at
least three (ideally five) days per week at a moderate level and to record their exercise
time on the exercise log. Exercise was defined as additional time during the day separate

37
from work or other normal daily activities. Appendix E contains the exercise handout
given to participants.
For the purposes of this study participants were judged to have been compliant
with the exercise portion of the intervention if their average exercise minutes during a
week were greater than or equal to 135 minutes (45 minutes per day for 3 days). Weekly
minutes were totaled for the time period and the average for the time period their
determined their compliance for that time period (baseline to day 30, day 31 to day 90,
day 91 to day 180). The participant was determined to compliant overall if they were
compliant for two (2) of the three (3) periods evaluated. Table 4.3 shows the exercise
compliance for each participant at day 30, day 90, day 180, and their overall compliance
rating. Eighty percent (80%) of the participants were compliant with the exercise portion
of the intervention. The compliance average ranged from a high of 337.69 minutes (60
minutes a day for 5.6 days a week) per time period to a low of 144.23 minutes (45
minutes a day for 3.2 days a week) per time period.
Diet. The dietary segment of the intervention was also evaluated on a compliant
noncompliant basis. The participants were encouraged to modify their current dietary
practices to coincide with the recommended servings for specific food groups (see
appendix F).
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Table 4.3
Average Minutes Exercised by Participant, Time Period, and Overall Rating
Participant

Day 30

Day 90

Day 180

Average
Minutes

Overall
Rating

4

78.75

140.63

67.31

95.56

Noncompliant

6

206.25

226.25

144.62

192.37

Compliant

8

183.75

101.25

147.69

144.23

Compliant

9

315

301.88

293.08

303.32

Compliant

14

333.75

341.25

338.08

337.69

Compliant

To evaluate compliance the recommended daily servings were averaged for each
week. If the recommended daily servings for the week was greater than or equal to the
recommended servings the participant was judged to be compliant for that food group. If
the number of compliant food groups for the week was greater than or equal to the
number of noncompliant food groups then the participant was judged to be compliant
with the dietary component for that week. If the weeks of compliance for the time period
(baseline to day 30, day 31 to day 90, day 91 to day 180) were greater than or equal to the
number of weeks of noncompliance then the participant was judged to be compliant for
that time period. If the participant was compliant for two of the three time periods they
were judged to be compliant with the dietary portion of the intervention. Table 4.4 show
the dietary compliance for each participant at day 30, day 90, day 180, and their overall
compliance rating.
As can be observed in table 4.4 only one participant (20 percent) was compliant
with the dietary portion of the intervention. This low level of compliance makes
evaluation of the impact of dietary changes difficult. Table 4.5 demonstrates the average
daily serving change for each participant by food groups. This difference was obtained by
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comparing the daily average servings by food group for the first four weeks of the study
and comparing them to the daily average servings by food group for the last four weeks
of the study. This reason for this evaluation is to look for positive changes in eating
habits of the 180 days of the study.
Participant 4 had overall the largest average change of dietary practices over the
180 days of the study at 0.4608 servings. He increased his grains, vegetables, and
nuts/seeds/legumes/beans by more than 1.5 servings a day and decreased his sweets and
red meat.
Table 4.4
Dietary Compliance by Participant, Time Period, and Overall Rating

Participant

Day 30

Day 90

Day 180

Overall Rating

4

Compliant

Compliant

Compliant

Compliant

6

Noncompliant

Noncompliant

Noncompliant

Noncompliant

8

Noncompliant

Noncompliant

Noncompliant

Noncompliant

9

Noncompliant

Noncompliant

Noncompliant

Noncompliant

14

Noncompliant

Noncompliant

Noncompliant

Noncompliant
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Table 4.5
Average Daily Serving Change for Each Participant by Food Group

Food Group

Participant
4 Daily
Average
Change

Participant
6 Daily
Average
Change

Participant
8 Daily
Average
Change

Participant
9 Daily
Average
Change

Participant
14 Daily
Average
Change

Grains

1.56

1.05

-0.10

2.58

0.19

Vegetables

1.50

0.94

0.48

-0.08

-1.58

Nuts/Seed/Legumes/
Beans

2.33

0.27

-0.20

-0.32

0.04

Fruit

0.36

-0.71

-0.04

-0.96

0.54

Olive Oil

0.32

-0.25

-0.07

0.93

0.14

Cheese & Yogurt

-0.19

-0.72

-0.28

0.58

0.53

Red Wine

-0.07

0.00

1.00

0.30

0.54

Fish

-0.28

-0.25

0.04

-2.46

0.14

Poultry

0.16

0.35

-0.44

-1.79

-0.83

Eggs

0.00

0.00

-0.13

-0.04

0.17

Sweets

-0.08

2.50

0.53

-0.79

-0.18

Red Meat

-0.08

0.61

0.24

-0.05

0.06

Average Change

0.4608

0.3158

0.0858

-0.175

-0.02

* Negative number indicates decrease in number of average daily servings.
This chapter is a review of the subjects and the results of the dietary and exercise
interventions on the various metabolic components. The compliance of the subjects with
the exercise and dietary interventions was also reviewed as well as the average overall
changes in serving changes for the selected food groups from the first week of the study
to the last week of the study.
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Chapter Five: Discussion
This chapter provides a discussion of the project outcomes and issues that
developed during the completion of the project. This is followed by a discussion of the
limitations of the study as well as recommendations for future projects of this subject and
for future research.
Discussion
The purpose of this project was to identify the effects of an intensive dietary and
exercise program on patients with metabolic syndrome. Specifically, the project was to
examine the effects of the program on waist circumference, blood pressure, HDL
cholesterol, triglycerides, and fasting glucose. By extension the desired outcome was to
move patients from a prothrombotic metabolic syndrome state to a less prothrombotic
non-metabolic syndrome state. None of the five participants who completed the study
moved to the non-metabolic state. All but one participant were compliant with the
exercise portion. Interestingly, this person was the only one who was compliant with the
dietary portion of the intervention.
The evidence suggests that diet and exercise programs are effective in controlling
the components of metabolic syndrome. But, as with this study, the complexity of dietary
and exercise interventions are complex impede adherence, both in execution and
evaluation. These types of interventions require significant lifestyle changes and if they
are to be successful the participants must exhibit concerted long term effort.
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Limitations and Challenges
There were multiple challenges in this project. These include issues related to the
sample, the metabolic components, adherence to the intervention, and even the selection
of participants.
Sample. The final sample size was five participants (three male and two female).
This small sample size at the completion of the study precludes dynamic statistical
evaluation. Future projects of this type should begin with a more robust initial sample
size. If possible a beginning sample size of at least 100 participants would be more
appropriate. With an expected attrition of approximately 50% there would be a more
realistic approximation of a normal distribution.
This increased number of participants would increase the complexity of the
logistics and record keeping. Multiple meeting days and times may be necessary to
accommodate the participants and their individual needs. A meeting area large enough to
accommodate the maximum number of participants would be required and since the
biometrics are taken in a fasting state a greater amount of appropriate foods would be
required for participant consumption at each meeting. Increasing the number of
participants would also increase the cost of the study and funding would need to be
addressed at an early stage. A specific data entry individual would be required if there
were an increased number of participants. The primary investigator would have a difficult
time performing as data entry, coordinator, and exercise counselor. It would also be
desirable to have input from a statistician at a very early stage to assist with set up of
Excel and SPSS type programs prior to beginning of data collection.
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Metabolic components. The small sample size (n=5) did not lend itself to strong
statistical evidence of change in the metabolic components. However, the small sample
size did not preclude the outcome of a statistically significant decrease in waist size.
Although not statistically significant, systolic blood pressure and high density lipoprotein
(HDL) trended in the desired direction (down for SBP and up for HDL). An increase in
the number of participants or a lengthening of the study period (preferably both) may
have produced more dynamic changes in these metabolic components. In contrast, the
glucose and triglycerides averages were trending upward. Again the sample size was too
small to hypothesis with any degree of certainty the possible explanation.
The overall compliance with the exercise regimen may account for some of the
improvement in waist size, blood pressure, and HDLs. The literature from Carroll and
Dudfield (2004) and my own anecdotal clinical experience, indicates that waist size,
blood pressure, and HDL are affected more by exercise rather than diet, while glucose
and triglycerides seem to be less affected by exercise. This is an important aspect for
future research.
Diet and exercise. The exercise portion of the intervention was the easier of the
two to track and had a significantly higher adherence rate when compared to diet. One
possible explanation is that exercise is a finite time commitment during the day while
dietary changes are necessary throughout the day and are therefore more difficult to
maintain and track. Another difference that adds to the complexity of diet as compared to
exercise is that there are 12 components to the dietary intervention and one component to
the exercise component. An addition to the data collection should have been to establish
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pre-study levels of exercise and compare them to post-study levels of exercise. This could
have shown if there was a change in life style with reference to exercise.
As would be expected the dietary portion of the intervention was more
complicated and time consuming for the participants. This is inherent in any dietary
intervention that is designed to significantly change dietary lifestyle. Another difficulty
with the dietary portion was overcoming the cultural differences in the diet. The
Mediterranean style of eating is vastly different from the typical southeastern United
States diet. This difference could have been blunted by limiting the number of food
groups evaluated. The dietary portion also presented several barriers to change that had
not been addressed in the initial planning of the study. The participants did not accept the
need for the changes in their diet, they preferred their current diets because of tradition,
and many were set in their ways and did not truly wish to make dramatic changes in their
habits.
Record keeping and meetings. Self reporting has inherent problems one of which
is the constant possibility of inaccurate information being submitted. It is difficult to
judge the accuracy of entries in self reporting type data. Some reasons for this possible
inaccuracy include the participant wanting to appear to be compliant in order to be
praised by the researchers. They may also know and or like the researcher, they might
feel that a greater appearance of compliance may help the researcher. These biases would
be difficult if not impossible to overcome without making the collection process much
more complicated. If the collection process were more complicated the researchers would
run the risk of decreasing participation.
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Meeting at 90 and 180 days decreased the number of data points and made it
difficult to note small incremental changes. Monthly meetings would have had several
positive impacts. This increased frequency of meetings would have made it possible to
intervene with counseling earlier and would have reinforced good changes and allowed
for changing non helpful changes prior to them being made permanent. Monthly
meetings would also have allowed for identifying individual barriers to diet and exercise
as well as the opportunity to overcome the barriers. Having monthly meetings would
have increased the number of data points, but would have also increased the scheduling
problems for participants which could have increased the dropout rate. As previously
mentioned an increase in the number of meetings would also have increased the monetary
cost of the project.
Selection of participants. It is difficult to gage the success of the interventions if
the participant is currently taking medications for hypertension or dyslipidemia. It may be
construed as unethical to expose participants to the increased risk of end organ damage
and adverse events by stopping their existing medications. Ideally the target population
for this type of intervention would be individuals who meet the diagnostic criteria for
metabolic syndrome, but have not been placed on medication. This early intervention is
possible by selectively targeting individuals with metabolic syndrome who are
medication naive.
Implications for Future Research
Future research at the practice level should target dietary changes of five food
groups rather than the 12 in this study. The food groups to target would be increase olive
oil, fish/chicken, and whole grains, as well as decrease concentrated sweets and red
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meats. This less intensive intervention would allow the participants to make less extreme
dietary changes and would be less of a challenge to the southern culture of food choices.
Since the changes would be less extreme the complexity of participant record keeping
would be decreased and could thereby increase adherence.
Future research at the practice level targeting exercise changes should
differentiate the changes that take place with different types of moderate exercise as well
as between age groups, and genders. This would allow more precise targeting of exercise
interventions by types of exercises, age group, and gender.
Implications for Practice
The research undertaken for this project has clarified dietary and exercise advice
given to patient with metabolic syndrome. The dietary suggestions to increase olive oil,
fish/chicken, and whole grains and decrease concentrated sweets and red have been
incorporated into the standards of care at my practice setting. Dietary and exercise
interventions have been incorporated into suggested lifestyle changes for pre-metabolic
syndrome patients as well as metabolic syndrome patients.
If these dietary and exercise changes can be implemented prior to an actual
diagnosis of metabolic syndrome it would, in all likely hood, decrease the incidence of
metabolic syndrome and thereby decrease the prevalence of heart disease and diabetes.
Conclusion
Metabolic syndrome continues to be a serious health problem in the United States.
The presence of metabolic syndrome significantly increases the risk of developing type II
diabetes and cardiovascular disease by producing a prothrombic state. The independent
risk factors that create this prothrombic state increases the risk of micro and macro
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vascular changes and eventually to end organ damage. Dietary and exercise lifestyle
changes are effective at changing this prothrombis state. The challenge is motivating the
individuals to make the necessary lifestyle changes prior to end organ damage.
This study even with a small sample size showed that waist size, systolic blood
pressure, diastolic blood pressure, and high density lipoprotein levels were trending
towards levels that would remove the patient from the diagnosis of metabolic syndrome.
The largest benefit for the general population would result from intervention prior to a
diagnosis of hypertension and diabetes. This would help decrease the cost of medical
treatment and hospitalization.
If early intervention would decrease only systolic blood pressure by 12 – 13
mmHg over 4 years a corresponding decrease of 21% in coronary heart disease, a
decrease of 37% in stroke, and a decrease of 25% in cardiovascular deaths could be
expected(USDHHS, 2005). This decrease in coronary heart disease, stroke, and
cardiovascular death would translate in to billions of dollars save in health care
expenditures.

Appendix A. Review of the Evidence
Author
Type
(Dates)
Meta-analysis and systematic reviews
Gami et al.
Meta-analysis and systematic
(2007)
review of longitudinal studies
of metabolic syndrome and
incidence of cardiovascular
events and death.
Mellen et al. Meta-analysis of the effects of
(2006).
whole grain intake on
cardiovascular disease

N

Comments

36 studies, 172,573
subjects

Purpose was to assess the association between metabolic syndrome and
cardiovascular events and death by reviewing longitudinal studies.
Evidence suggested metabolic syndrome increased the risk of
cardiovascular events and death.

7 studies, 285,376
subjects

Epidemiological cohort studies showing an inverse relationship
between whole grain intake and CVD. 2.5 servings daily associated
with a 21% decrease in risk of CVD. 229 post menopausal women
study showed 6 or more servings per week was associated with a 40%
decrease in coronary atherosclerotic progression.
13 countries represented, conclusion that scientific evidence for
Mediterranean Diet was observational and personal reviews. 24 of the
43 studies included less than 60 subjects. Authors found that
Mediterranean diet recommendations needed to be evidenced based and
observational epidemiological studies were needed in the
Mediterranean countries.
RCTs comparing dietary counseling-based weight loss against usual
care produced a mean net treatment effect of approximately 6% (5kg)
of weight loss at 1 year. Modest weight loss reduces cardiovascular risk
factors hyperglycemia, hypertension, & hypercholesterolemia. Modest
weight loss through dietary and lifestyle counseling reduces risk of
development of diabetes in glucose-intolerant individuals.
All studies with a minimum of 1 year of follow-up, dependent variable
weight-loss in treatment verses control arm. Treatments included
exercise alone, diet alone, diet & exercise, meal replacements, verylow-energy diet, orlistat, sibutramine, and advice alone. Interventions of
diet alone, diet and exercise, and meal replacement decreased weight by
5 – 9% at 6 months, then plateau with a 4.8 – 8% stabilization at 12

Serra-Majem Systematic review of
outcomes of the use of the
et al.
(2006)
Mediterranean diet

43 clinical
trials,17031 subjects

Dansinger
et al.
(2007)

Meta-analysis on effect of
dietary counseling for weight
loss

40 studies with 63
treatment groups, 26
with diet and 27 with
diet and exercise

Franz et al.
(2007)

Systematic review & metaanalysis of weight-loss clinical
trials with a minimum of 1
year of follow-up

80 studies included
with 26,455 subjects
enrolled and
randomized and a
overall attrition rated
of 31%
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Author
(Dates)

Type

N

Comments
months and 3 – 4.3% reduction out to 48 months. Weight loss and
maintenance for diet medications is similar to diet plus exercise at 6
months, but a mean weight loss of 2 – 5% above exercise intervention
is noted at 24 months. Very-low-energy diets resulted in dramatic
weight loss followed by rapid and substantial weight gain. Exercise
alone or advice did not result in successful weight loss, but no weight
gain was noted.

Reviews
Carroll &
Dudfield
(2004)

Review of the relationship
between exercise, diet and
metabolic syndrome.

Giugliano
& Esposito,
(2008)

Review of Studies

20 male prevalence
studies, 93111
subjects; 15 female
prevalence studies,
64973 subjects; 6
cross-sectional & 1
prospective studies,
22521 subjects; 3
IGT RCTs studies,
4333 subjects; 15
exercise RCTs, 1017
subjects;
N/A

Johnson &
Weinstock
(2006)

Review for Clinicians

N/A

Kaplan, &
Keil,

Review Literature

N/A

Epidemiology reviewed, prevalence of metabolic syndrome clustered
by age groups reviewed, reviewed exercise recommendations, dietary
recommendations, positive effects of exercise and dietary changes.
Authors did not review inclusion criteria for articles. Validity of studies
was not discussed. Possible relevant articles may have been overlooked
although Table XI did give characteristics of methodology of RCTs
evaluated. 30 to 60 min exercise 3 – 5 times a week at 40 – 60% VO2
max shows positive outcome with reducing metabolic syndrome.

Review of studies involving Mediterranean diet and obesity,
cardiometabolic risk, diabetes, metabolic syndrome as well as the
possible protective mechanism of Mediterranean diet.
Review of the three diagnostic criteria for metabolic syndrome, review
of controversies around the differences in the diagnostic criteria.
Metabolic syndrome is an indicatory of long-term cardiovascular risk
and Framingham is superior for short term risk assessment for
cardiovascular risk. ADA and EASD question the clinical value of
metabolic syndrome. Discusses flaws with ATP III criteria.
Review of literature with reference to CVD risk factors and
socioeconomic status and the factors related to socioeconomic status.
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Author
(Dates)
(1993)

Larion,
Denis
(2007)

Type

N

Review of Studies; Primary &
Secondary Prevention,

Primary Prevention 4
studies N=1123,
Secondary Prevention
2 studies N=11928

Practice Guidelines

N/A

U.S.
Depatemtnet
of Health
and Human
Services
(2003)

Clinical Guidelines
JNC-7

N/A

American
Diabetes

Clinical Guidelines
Standards of medical care in

N/A

Guidelines
Armstrong,
(2006)

Comments
Discusses measurement of socioeconomic status/social class most
common being education level, income, occupation, employment
status, indexes of social class, measures of living conditions, are-based
measures, life span measures, measures of income inequality. Reviews
all cause mortality and CV mortality by SES. Risk factors of CV
disease discussed and compared by SES. Questions if SES is an
independent risk factor for CV disease.
The Mediterranean-type diet lowered BMI, total, LDL- and
triglyceride, insulinemia, and glycemia. Mediterranean-style diet
promoted beneficial changes for fasting glucose, systolic blood
pressure, the cholesterol/HDL cholesterol ratio. Mediterranean style
diet was compared with low fat low cholesterol diet and Mediterranean
proved more beneficial.
Primary goal to reduce risk for CVD, first line therapy related to major
risk factors (elevated LDL, HTN, DM), Metabolic syndrome rarely
manifests in the absence of obesity and physical inactivity. Clinical
management goals reviewed for abdominal obesity, physical activity,
diet, dyslipidemia, elevated blood pressure, prothrombic and
proinflammatory states, and elevated fasting glucose
Guidelines for management of HTN. The ultimate goal of therapy is to
reduce cardiovascular & renal morbidity & mortality. A healthy
lifestyle by all persons is critical for the prevention of HTN & is
essential part of the management of those with HTN. Major lifestyle
modifications are shown to lower BP (weight reduction in overweight
or obese, adoption of the Dietary Approaches to Stop Hypertension
(DASH) eating plan which is rich in potassium and calcium, dietary
sodium reduction, physical activity, & moderation of alcohol
consumption.
National guidelines for diagnosis and management of diabetes.
Hperglycemia insufficient to be diagnosed as diabetes is referred to as
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Author
(Dates)
Association
(2007)

Type

N

diabetes.

National
Institutes of
Health, ATP
III,
(2001)
Studies
Simons,
et al.,
(2007)

Clinical Guidelines

N/A

Longitudinal cohort study

2085

Lorenzo,
et al.,
(2007)

Longitudinal cohort study

2646

Loucks,
et al.,
(2006)

Cross-sectional study

11107

Comments
as either IFG or impaired glucose tolerance (IGT), depending on
whether it is identified through an FPG or an OGTT: ● IFG FPG 100
mg/dl (5.6 mmol/l) to 125 mg/dl (6.9 mmol/l), ● IGT 2-h plasma
glucose 140 mg/dl (7.8 mmol/l) to 199 mg/dl (11.0 mmol/l)
Recently, IFG and IGT have been officially termed pre-diabetes. Both
categories,
IFG and IGT, are risk factors for future diabetes and cardiovascular
disease.
ATP III guidelines for lowering cholesterol and establishing criteria for
metabolic syndrome. Therapeutic life style changes recommended.
Dietary recommendations included.

60 years old or older followed for 16 years; Duppo New South Wales;
main outcome measures CHD events, ischemic stroke, total mortality.
Results metabolic syndrome increased risk in older individuals for
CHD events, stroke events, and total mortality greater than general
population of same age.
Ages 25 - 64 with 7.4 years of follow-up; conclusion metabolic
syndrome is associated with a significant increase risk of CVD
especially in men older than 45 & women older than 55. Metabolic
syndrome increases CVD risk in people who are free of CVD or DM.
CVD risk prediction by metabolic syndrome is inferior compared to
Framingham. Compared ATP III, IDF, and WHO definitions all have a
similar ability to predict CVD & diabetes, but they have differing
sensitivity and false positive rate.
Used NCEP-R diagnosis criteria; SEP measured by education or
income is associated with metabolic syndrome in women (white, black,
and Mexican-American), black women education 12 years, but not <12
years was linked to metabolic syndrome; mechanisms that link SEP to
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Author
(Dates)

Type

N

Santos, et al.
(2008)

Cross-sectional cohort study

1962

Guize,
et al.
(2007)

Longitudinal cohort study

60754

Belahsen &
Rguibi
(2006)

Population

N/A

Expert Opinion

N/A

Comments
metabolic syndrome health behaviors, psychological stress, & access to
health care.
Location Portugal, gender influenced the association of socio-economic
status with metabolic syndrome. Lower socio-economic class defined
by education and occupation. Females in lower classes increased
prevalence men no association noted.
French study; men aged 52.6 +/- 8.3, women aged 54.7 +/-; mean
follow-up 3.57 years +/- 1.12; prevalence of metabolic syndrome
adjusted for age, sex, classical risk factors, socioprofessional standing;
used ATP III, NCEP-R, and IDF definitions; three and four component
combinations that showed increased risk of all cause mortality.
Study discussing trends in southern Mediterranean countries with
reference to diet and activity levels. Away from traditional Med diet
towards western diet and the increasing incidence of obesity in the area.

Expert Opinion

Stone, &
Schmeltz,
(2007)

Reviewed epidemic of metabolic syndrome and obesity, clinical impact,
(CVD, DM II, inflammation & prothrombotic state), treatments
(lifestyle modification, pharmacology, surgery) & expert opinion on
how to treat metabolic syndrome – treat each of its individual
components, pharmacologic therapy crucial, but relying solely on
medications may be counter productive, focus on root causes and start
with therapeutic lifestyle changes (diet, exercise).
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Appendix B

Patient Profile
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Appendix C

Data Collection Form
Participant Number
Data

Variable
Baseline
Date
Age (years)
Gender
Smoking status (packs per day)
Height (inches)
Weight (pounds)
Waist circumference (cm)
Glucose (mmol/l)
Systolic blood pressure
(mmHg)
Diastolic blood pressure
(mmHg)
Triglycerides (mmol/l)
High-density
lipoprotein(mmol/l)
Low-density lipoprotein
(mmol/l)

30 Days

90 Days

180 Days
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Appendix D

Exercise Handout
Exercise

1. What is physical activity?
Physical activity simply means movement of the body that uses energy. Walking, gardening,
briskly pushing a baby stroller, climbing the stairs, playing soccer, or dancing the night away are
all good examples of being active.
•

Moderate physical activities include:
o
o
o
o
o
o
o

•

Walking briskly (about 3 ½ miles per hour)
Hiking
Gardening/yard work
Dancing
Golf (walking and carrying clubs)
Bicycling (less than 10 miles per hour)
Weight training (general light workout)

Vigorous physical activities include:
o
o
o
o
o
o
o
o

Running/jogging (5 miles per hour)
Bicycling (more than 10 miles per hour)
Swimming (freestyle laps)
Aerobics
Walking very fast (4 ½ miles per hour)
Heavy yard work, such as chopping wood
Weight lifting (vigorous effort)
Basketball (competitive)

Some physical activities are not intense enough to help you meet the recommendations. Although
you are moving, these activities do not increase your heart rate, so you should not count these
towards the 45 or more minutes a day that you should strive for. These include walking at a
casual pace, such as while grocery shopping, and doing light household chores.
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2. Why is physical activity important?
Being physically active is a key element in living a longer, healthier, happier life. It can help
relieve stress and can provide an overall feeling of well-being. Physical activity can also help you
achieve and maintain a healthy weight and lower risk for chronic disease. The benefits of physical
activity may include:
•
•
•
•
•
•
•
•
•

Improves self-esteem and feelings of well-being
Increases fitness level
Helps build and maintain bones, muscles, and joints
Builds endurance and muscle strength
Enhances flexibility and posture
Helps manage weight
Lowers risk of heart disease, colon cancer, and type 2 diabetes
Helps control blood pressure
Reduces feelings of depression and anxiety

Physical activity and nutrition work together for better health. Being active increases the amount
of calories burned. As people age their metabolism slows, so maintaining energy balance requires
moving more and eating less.
Some types of physical activity are especially beneficial:
•
•

•

Aerobic activities – speeds heart rate and breathing and improves heart and lung
fitness. Examples are brisk walking, jogging, and swimming.
Resistance, strength building, and weight-bearing activities – helps build and maintain
bones and muscles by working them against gravity. Examples are carrying a child,
lifting weights, and walking. They help to build and maintain muscles and bones.
Balance and stretching activities – enhances physical stability and flexibility, which
reduces risk of injuries. Examples are gentle stretching, dancing, yoga, martial arts,
and t’ai chi.

3. How much physical activity is needed?
•

•

•

At a minimum, do moderate intensity activity for 45 minutes. Try to exercise at least 5
days a week, but preferably every day. This is in addition to your usual daily activities.
Increasing the intensity or the amount of time of activity can have additional health
benefits and may be needed to control body weight.
About 60 minutes a day of moderate physical activity may be needed to prevent weight
gain. For those who have lost weight, at least 60 to 90 minutes a day may be needed to
maintain the weight loss. At the same time, calorie needs should not be exceeded.
While 30 minutes a day of moderate intensity physical activities provide health
benefits, being active for longer or doing more vigorous activities can provide
even greater health benefits. They also use up more calories per hour. No
matter what activity you choose, it can be done all at once, or divided into two
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or three parts during the day. When dividing exercise during the day 10-minute bouts
of activity count toward your 45 minute total.
4. Calories used:
A 154-pound man (5’ 10”) will use up about the number of calories listed doing each activity
below. Those who weigh more will use more calories, and those who weigh less will use
fewer. The calorie values listed include both calories used by the activity and the calories used
for normal body functioning.

Approximate calories used
by a 154 pound man
Moderate physical activities:

In 1 hour

In 30 minutes

Hiking

370

185

Light gardening/yard work

330

165

Dancing

330

165

Golf (walking and carrying clubs)

330

165

Bicycling (less than 10 miles per hour)

290

145

Walking (3 ½ miles per hour)

280

140

Weight training (general light workout)

220

110

Stretching

180

90

In 1 hour

In 30 minutes

Vigorous physical activities:
Running/jogging (5 miles per hour)

590

295

Bicycling (more than 10 miles per hour)

590

295

Swimming (slow freestyle laps)

510

255

Aerobics

480

240

Walking (4 ½ miles per hour)

460

230

Heavy yard work (chopping wood)

440

220

Weight lifting (vigorous effort)

440

220

Basketball (vigorous)

440

220

5. Tips for increasing physical activity.
•

Make physical activity a regular part of the day. Choose activities that you enjoy and
can do regularly. Fitting activity into a daily routine can be easy—such as taking a brisk
10 minute walk to and from
the parking lot or bus stop.
Join an exercise class. Keep
it interesting by trying
something different on
alternate days. What’s
important is to be active most
days of the week and make
it part of daily routine. For
example, to reach a 30minute goal for the day, walk
the dog for 10 minutes
before and after work, and
add a 10 minute walk at
lunchtime. Swim 3 times a
week and take a yoga class
on the other days. Make sure to do at least 10 minutes of the activity at a time, shorter
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bursts of activity will not have the same health benefits. To be ready anytime, keep some
comfortable clothes and a pair of walking or running shoes in the car and at the office.
•

At home: Join a walking
group in the neighborhood
or at the local shopping
mall. Recruit a partner for
support and
encouragement. Push the
baby in a stroller. Get the
whole family involved—
enjoy an afternoon bike
ride with your kids. Walk
up and down the soccer or
softball field sidelines
while watching the kids
play. Walk the dog—don’t
just watch the dog walk.
Clean the house or wash
the car. Walk, skate, or
cycle more, and drive less.
Do stretches, exercises, or pedal a stationary bike while watching television. Mow the
lawn with a push mower. Plant and care for a vegetable or flower garden Play with the
kids—tumble in the leaves, build a snowman, splash in a puddle, or dance to favorite
music.

•

At work: Get off the bus or subway one stop early and walk or skate the rest of the
way. Replace a coffee break with a brisk 10-minute walk. Ask
a friend to go with you. Take part in an exercise program at
work or a nearby gym. Join the office softball or bowling team.
Use the stairs not the elevator. Do not use the closest rest room
to your office.

•

At play: Walk, jog, skate, or cycle. Swim or do water aerobics.
Take a class in martial arts, dance, or yoga. Golf (pull cart or
carry clubs). Canoe, row, or kayak. Play racket ball, tennis, or squash. Ski crosscountry or downhill. Play basketball, softball, or soccer. Hand cycle or play wheelchair
sports. Take a nature walk. Most important – have fun while being active!

This handout was adapted from information obtained from
http://www.mypyramid.gov/pyramid/physical_activity.html
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Appendix E

Recommended Servings of Food Groups

Food Group

Recommended Servings per Week

Serving Size

Sweets

Maximum of 7

1 teaspoon

Red Meat

Maximum of 4

3 ounces

Grains

Minimum of 42

1 slice of bread, ½ bagel,
1 cup cereal,
½ cup pasta or rice

Eggs

Maximum of 3

1 egg

Poultry

Minimum of 3

3 ounces

Fish

Minimum of 3

3 ounces

Wine

Minimum of 7

3 – 4 ounces

Olive oil

Minimum of 4

1 tablespoon

Fruits

Minimum of 21

1 cup fresh, ½ cup canned,
½ cup dried

Beans, legumes, nuts Minimum of 14

Nuts/Seeds 1 ounce,
Beans/Legumes ½ cup

Vegetables

Minimum of 21

1 cup raw, ½ cup cooked

Cheese & yogurt

Minimum of 14

Cheese 1 ounce,
Yogurt 1 cup
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